Aberdeen Group’s Abiomed Inc ABMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-30,611
| Closed | -$7.52M | – | 936 |
|
|
2022
Q3 | $7.52M | Buy |
30,611
+11,795
| +63% | +$2.9M | 0.02% | 485 |
|
|
2022
Q2 | $4.75M | Buy |
18,816
+4,073
| +28% | +$1.03M | 0.01% | 556 |
|
|
2022
Q1 | $5.02M | Sell |
14,743
-752
| -5% | -$256K | 0.01% | 575 |
|
|
2021
Q4 | $5.57M | Sell |
15,495
-610
| -4% | -$219K | 0.01% | 619 |
|
|
2021
Q3 | $5.3M | Buy |
16,105
+1,212
| +8% | +$399K | 0.01% | 644 |
|
|
2021
Q2 | $4.65M | Sell |
14,893
-631
| -4% | -$197K | 0.01% | 664 |
|
|
2021
Q1 | $4.95M | Buy |
15,524
+446
| +3% | +$142K | 0.01% | 648 |
|
|
2020
Q4 | $4.89M | Buy |
15,078
+1,179
| +8% | +$382K | 0.01% | 610 |
|
|
2020
Q3 | $3.85M | Sell |
13,899
-2,037
| -13% | -$564K | 0.01% | 608 |
|
|
2020
Q2 | $3.85M | Sell |
15,936
-1,307
| -8% | -$316K | 0.01% | 601 |
|
|
2020
Q1 | $2.5M | Sell |
17,243
-270
| -2% | -$39.2K | 0.01% | 636 |
|
|
2019
Q4 | $2.99M | Sell |
17,513
-179,976
| -91% | -$30.7M | 0.01% | 672 |
|
|
2019
Q3 | $35.1M | Buy |
197,489
+1,227
| +0.6% | +$218K | 0.09% | 197 |
|
|
2019
Q2 | $51.1M | Buy |
196,262
+35,973
| +22% | +$9.37M | 0.11% | 159 |
|
|
2019
Q1 | $45.8M | Buy |
160,289
+11,278
| +8% | +$3.22M | 0.1% | 183 |
|
|
2018
Q4 | $47.1M | Buy |
149,011
+24,819
| +20% | +$7.84M | 0.11% | 155 |
|
|
2018
Q3 | $55.9M | Buy |
124,192
+2,095
| +2% | +$942K | 0.1% | 184 |
|
|
2018
Q2 | $50M | Sell |
122,097
-9,112
| -7% | -$3.73M | 0.1% | 199 |
|
|
2018
Q1 | $38.2M | Buy |
131,209
+23,930
| +22% | +$6.96M | 0.08% | 249 |
|
|
2017
Q4 | $20.1M | Buy |
+107,279
| New | +$20.1M | 0.04% | 352 |
|